New drug cocktail aims to knock out blood cancer
NCT ID NCT01559935
Summary
This study tested a combination of four medications for adults newly diagnosed with multiple myeloma, a blood cancer. The goal was to see if adding a newer drug called carfilzomib to an existing three-drug regimen could better control the disease and improve patient outcomes. Researchers measured how well the treatment worked, its side effects, and how long patients lived without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Weill Cornell Medical College
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.